freestyle libre flash glucose monitoring system for sale

#Freestyle libre flash glucose monitoring system for sale registration
#Freestyle libre flash glucose monitoring system for sale android
#Freestyle libre flash glucose monitoring system for sale professional

ResultsĪs compared with the baseline, positive differences were found after 12 weeks of FSL use for all of the items in the DTSQ ( p < 0.001) and the WHO-5 questionnaire ( p < 0.001).

At baseline and 12 weeks, a trained interviewer administered the Arabic version of the Diabetes Treatment Satisfaction Questionnaire (DTSQ) and the WHO-5 Well-Being Index (WHO-5) (1998 version) questionnaire. At the baseline visit, FSL sensors were placed on each participant by a trained diabetes educator. Study participants (aged 14–21 years) were treated for type 1 diabetes with an insulin pump (IP) ( n = 10) or multiple dose injections (MDI) ( n = 23), and used the conventional finger-pricking method for glucose self-testing. MethodsĪ 12-week prospective study was conducted from January 2018 to May 2018 at the Diabetes Treatment Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia. The product images are for illustrative purposes only.This study assessed the treatment satisfaction and sense of well-being attained when patients with type 1 diabetes use the FreeStyle Libre flash glucose monitoring system (FSL Abbott Diabetes Care, Inc., Alameda, CA, USA). This website and the information contained herein is intended for use by residents of Singapore. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company. Other trademarks are the property of their respective owners. Please read the Legal Notice for further details.įreeStyle, Libre and related brand marks are trademarks of Abbott Diabetes Care Inc. Always read the label and use as directed.įor more information call Customer Service on 1 8 or +65 3138 3799. Health care professionals and consumers should be aware about the limitations of available scientific evidence for use of this device in any other groups of patients who require diabetes management. The indication for children (age 4 – 17) is limited to those who are supervised by a caregiver at least 18 years old who is responsible for supervising, managing, and assisting the child in using the FreeStyle Libre system and interpreting its readings. The FreeStyle Libre flash glucose monitoring system is indicated for measuring interstitial fluid glucose levels in people (age 4 and older) with diabetes mellitus. *Abbott’s calculation based in part on data reported by Nielsen MarketTrack for Diabetic Supplement category, 12-month period ending February 2020, Singapore Total Scan Channels (Copyright© 2020).

#Freestyle libre flash glucose monitoring system for sale professional

Home users must consult a healthcare professional before making any medical interpretation and therapy adjustments from the information in the software.ġ6 LibreView is developed and distributed by Newyu, Inc. This device is not intended to replace self-monitoring practices as advised by a physician. The user should follow instructions on the continuous glucose monitoring system. Dosing decisions should not be made based on this device.

#Freestyle libre flash glucose monitoring system for sale android

FreeStyle Libre readers and sensors are provided by Abbott.ġ3 LibreLinkUp is compatible with Android phone running Android OS 4.4 and higher and iPhones running iOS 10 and higher.ġ4 Transfer of glucose data between applications depends on mobile connectivity.ġ5 LibreView is a secondary viewer and is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice. Data charges may apply when downloading the LibreLinkUp app.

#Freestyle libre flash glucose monitoring system for sale registration

Use of LibreLinkUp requires registration with LibreView, a service provided by Abbott and Newyu, Inc. A finger prick test using a blood glucose meter is required during times of rapidly changing glucose levels when interstitial fluid glucose levels may not accurately reflect blood glucose levels or if hypoglycaemia or impending hypoglycaemia is reported by the LibreLink app or when symptoms do not match the FreeStyle LibreLink app readings.ġ2 LibreLinkUp is a mobile application, developed and provided by Newyu. Data charges may apply when downloading the FreeStyle LibreLink app.ġ1 The FreeStyle LibreLink app and the FreeStyle Libre reader have similar but not identical features. Please check our compatibility guide for more information about device compatibility before using the app.ġ0 FreeStyle LibreLink is a mobile application. Weight: 5 grams.ĩ The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. # Bundle promotions valid while stocks last only.Ĩ Sensor dimensions: 35 mm x 5 mm. † Images and readings are for illustration purpose only.